KILITCH DRUGS(I)
Smallcap | BSE
Sector
Here's the live share price of Kilitch Drugs(I) along with daily highs, lows, percentage changes and volume trends, and, all financial information.
1.46₹ 2.55
As on Jul 24, 2026, 04:01 PM IST
Source: Dion Global
Kilitch Drugs(I) Price Performance
Today's LowToday's High
₹169.00₹180.50
₹177.20
52 Weeks' Low52 Weeks' High
₹121.10₹226.50
₹177.20
Open Price
₹174.65
Prev. Close
₹174.65
Volume
446
Source: Dion Global
Kilitch Drugs(I) Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Kilitch Drugs(I) | -3.70 | -7.30 | 17.55 | 13.41 | -16.82 | 25.43 | 12.56 |
| Sun Pharmaceutical Industries | 0.41 | 3.54 | 19.82 | 18.40 | 14.71 | 20.84 | 22.50 |
| Divi's Laboratories | -0.24 | 7.25 | 13.86 | 19.52 | 9.39 | 25.25 | 8.03 |
| Torrent Pharmaceuticals | 4.05 | 10.13 | 20.51 | 24.02 | 41.07 | 36.70 | 26.36 |
| Cipla | -0.60 | -1.91 | 8.90 | 7.40 | -5.20 | 10.37 | 8.20 |
| Zydus Lifesciences | -2.96 | 0.89 | 19.60 | 24.11 | 14.20 | 21.81 | 12.80 |
| Lupin | -2.79 | 0.26 | 3.39 | 10.54 | 22.16 | 36.31 | 15.17 |
| Mankind Pharma | 0.73 | 1.36 | 10.71 | 19.84 | -3.02 | 9.65 | 12.00 |
| Dr. Reddy's Laboratories | -4.81 | -13.23 | -12.41 | -7.05 | -8.87 | 2.24 | 1.28 |
| Aurobindo Pharma | -0.22 | 0.06 | 8.26 | 35.43 | 37.48 | 24.92 | 9.94 |
| Laurus Labs | 4.75 | 10.20 | 43.90 | 60.29 | 91.70 | 66.27 | 19.73 |
| Biocon | -0.86 | 2.74 | 23.91 | 18.62 | 8.98 | 20.23 | 2.15 |
| Alkem Laboratories | 1.38 | 3.65 | 7.66 | -2.17 | 12.64 | 14.20 | 10.47 |
| Glenmark Pharmaceuticals | -1.91 | 0.61 | -4.56 | 9.60 | 2.28 | 40.60 | 28.48 |
| Abbott India | 0.06 | 9.53 | 11.24 | 1.25 | -19.07 | 6.50 | 9.44 |
| Ipca Laboratories | -7.37 | 8.85 | 13.23 | 21.36 | 14.44 | 30.66 | 9.62 |
| Anthem Biosciences | -0.80 | -0.05 | 4.11 | 30.04 | 1.68 | 1.77 | 1.06 |
| GlaxoSmithKline Pharmaceuticals | 2.48 | 6.86 | 1.74 | 7.56 | -20.38 | 21.81 | 7.83 |
| Ajanta Pharma | -1.39 | 3.55 | 21.76 | 24.95 | 20.55 | 33.23 | 17.93 |
| Gland Pharma | -2.56 | 2.64 | 39.25 | 42.48 | 18.32 | 24.43 | -9.89 |
Source: Dion Global
Over the last one year, Kilitch Drugs(I) has declined 16.82% compared to peers like Sun Pharmaceutical Industries (14.71%), Divi's Laboratories (9.39%), Torrent Pharmaceuticals (41.07%). From a 5 year perspective, Kilitch Drugs(I) has outperformed peers relative to Sun Pharmaceutical Industries (22.50%) and Divi's Laboratories (8.03%).
Kilitch Drugs(I) Financials
Source: Dion Global
Kilitch Drugs(I) Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 181.02 | 180.91 |
| 10 | 180.81 | 181.88 |
| 20 | 186.04 | 183.16 |
| 50 | 181.05 | 178.99 |
| 100 | 165.69 | 173.73 |
| 200 | 170.33 | 173.25 |
Source: Dion Global
Kilitch Drugs(I) Share Holding Pattern
In the latest quarter, Kilitch Drugs(I) remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding rose to 0.12%, and public shareholding moved down to 36.11% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Kilitch Drugs(I) Corporate Actions
Date Time | Announcement |
|---|---|
| Jul 08, 2026, 11:19 PM IST IST | Kilitch Drugs(I) - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jun 17, 2026, 07:44 PM IST IST | Kilitch Drugs(I) - Announcement Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, |
| May 16, 2026, 12:42 AM IST IST | Kilitch Drugs(I) - Board Meeting Outcome for Submission Of Audited Standalone And Consolidated Financial Results For The Quar |
| May 16, 2026, 12:36 AM IST IST | Kilitch Drugs(I) - Audited Standalone And Consolidated Financial Results For The Quarter Ended 31St March, 2026 |
| May 16, 2026, 12:19 AM IST IST | Kilitch Drugs(I) - Announcement under Regulation 30 (LODR)-Monitoring Agency Report |
Source: Dion Global
About Kilitch Drugs(I)
Kilitch Drugs(I) Ltd. is a Public Limited Listed company incorporated on 12/05/1992 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1992PLC066718 and registration number is 066718. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 188.57 Cr. and Equity Capital is Rs. 34.96 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- AddressC-301/2, M.I.D.C., New Mumbai Maharashtra 400705
- Contact
Source: Dion Global
Management
- Mr. Mukund P MehtaManaging Director
- Mr. Bhavin Mukund MehtaWhole Time Director
- Mrs. Mira B MehtaWhole Time Director
- Mr. Hemang J EngineerIndependent Director
- Mr. Venkita Subramanian RajanIndependent Director
- Prof. Vasudev Krishna MurtiIndependent Director
- Mr. Dipen J JainIndependent Director
FAQs on Kilitch Drugs(I) Share Price
What is the share price of Kilitch Drugs(I)?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Kilitch Drugs(I) is ₹177.20 as on Jul 24, 2026.
What kind of stock is Kilitch Drugs(I)?
The Kilitch Drugs(I) is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Kilitch Drugs(I)?
The market cap of Kilitch Drugs(I) is ₹619.52 Cr as on Jul 24, 2026.
What are today's High and Low prices of Kilitch Drugs(I)?
Today’s highest and lowest price of Kilitch Drugs(I) are ₹180.50 and ₹169.00.
What are the 52 Week High and 52 Week Low of Kilitch Drugs(I)?
The 52-week high/low is the highest and lowest price at which Kilitch Drugs(I) stock has traded in the past 52-week or nearly a year. The 52-week high of Kilitch Drugs(I) is ₹226.50 and 52-week low of Kilitch Drugs(I) is ₹121.10 as on Jul 24, 2026.
How has the Kilitch Drugs(I) performed historically in terms of returns?
The Kilitch Drugs(I) has shown returns of 1.46% over the past day, -7.3% for the past month, 17.55% over 3 months, -16.82% over 1 year, 25.43% across 3 years, and 12.56% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Kilitch Drugs(I)?
P/E ratio of and PB ratio of Kilitch Drugs(I) are 20.54 and 2.22 on Jul 24, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global
✕